menu
    • menu

    Company profile for Celgene Corporation

    NEW Drugs in Dev: 16
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgen...
    At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Celgene CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    86 Morris Avenue, Summit, NJ 07901
    Telephone
    Telephone
    +1 (908) 673 9000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celgene.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celgene
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/celgene

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Vietnam Medi-Pharm Expo

    Not Confirmed

    envelop Contact Supplier

    Vietnam Medi-Pharm Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BMS skates again on $6.4B Celgene shareholder lawsuit
    BMS skates again on $6.4B Celgene shareholder lawsuit

    02 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/bms-skates-again-64b-celgene-shareholder-lawsuit-still-not-free-another-filing

    FIERCE PHARMA
    02 Oct 2024
    Share Share
    Celgene Corp's Reblozyl® (luspatercept-aamt) Receives Suppl Approval in US
    Celgene Corp's Reblozyl® (luspatercept-aamt) Receives Suppl Approval in US

    16 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136

    FDA
    16 May 2024
    Share Share
    Bristol Myers' bowel disease drug fails in late-stage study
    Bristol Myers' bowel disease drug fails in late-stage study

    29 Mar 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-bowel-disease-drug-fails-meet-main-goal-late-stage-study-2024-03-28/

    REUTERS
    29 Mar 2024
    Share Share
    Health Canada Issues Recall of Celgene Inc's ISTODAX (romidepsin) – Restricted Access Program
    Health Canada Issues Recall of Celgene Inc's ISTODAX (romidepsin) – Restricted Access Program

    20 Mar 2023

    // HEALTH CANADA

    https://recalls-rappels.canada.ca/en/alert-recall/istodax-romidepsin-restricted-access-program

    HEALTH CANADA
    20 Mar 2023
    Share Share
    Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay
    Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay

    02 Mar 2023

    // REUTERS

    https://www.reuters.com/legal/bristol-myers-wins-dismissal-lawsuit-over-celgene-drugs-2023-03-01/

    REUTERS
    02 Mar 2023
    Share Share
    Sun Pharma gets USFDA nod to market generic medication
    Sun Pharma gets USFDA nod to market generic medication

    10 Feb 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-gets-usfda-nod-to-market-generic-medication/articleshow/97795222.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    10 Feb 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Celgene Corporation and get a quotation

    Celgene Corporation is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find Marizomib bulk offered by Celgene Corporation

    Find Romidepsin bulk offered by Celgene Corporation

    Find Lenalidomide bulk offered by Celgene Corporation

    Find Thalidomide bulk offered by Celgene Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search